Literature DB >> 12791493

Self-treatment and its discussion in medical consultations: how is medical pluralism managed in practice?

Fiona A Stevenson1, Nicky Britten, Christine A Barry, Colin P Bradley, Nick Barber.   

Abstract

Recent policy changes in the UK such as deregulation of prescribed medicines and the introduction of telephone helpline services are intended to promote self-treatment. Drawing on interviews with, and consultations between, 35 patients and 20 general practitioners, we use Kleinman's (Patients and Healers in the context of culture: an exploration of the Borderland between Anthropology, Medicine and Psychiatry, University of California Press Ltd., London) model of the three sectors of health care in order to examine the range of self-treatments people use and the discussion of these treatments in medical consultations. We argue that despite the availability of a range of treatment options and policy changes advocating greater use of self-treatment, patients are inhibited from disclosing prior self-treatment, and disclosure is affected by patients' perceptions of the legitimacy of self-treatment. The findings are in keeping with Cant and Sharma's (A New Medical Pluralism, Alternative Medicines, Doctors, Patients and the State, UCL Press, London) contention that although there has been a pluralisation of "legitimate" providers of health care and a restructuring of expertise, biomedicine itself remains dominant.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12791493     DOI: 10.1016/s0277-9536(02)00377-5

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN: 0277-9536            Impact factor:   4.634


  30 in total

Review 1.  What information do patients need about medicines? "Doing prescribing": how doctors can be more effective.

Authors:  Glyn Elwyn; Adrian Edwards; Nicky Britten
Journal:  BMJ       Date:  2003-10-11

2.  Complementary and alternative medicine use as health self-management: rural older adults with diabetes.

Authors:  Thomas A Arcury; Ronny A Bell; Beverly M Snively; Shannon L Smith; Anne H Skelly; Lindsay K Wetmore; Sara A Quandt
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2006-03       Impact factor: 4.077

3.  Alternative medicine and doping in sports.

Authors:  Benjamin Koh; Lynne Freeman; Christopher Zaslawski
Journal:  Australas Med J       Date:  2012-01-31

Review 4.  A plea for a more epidemiological and patient-oriented pharmacovigilance.

Authors:  Veronica Scurti; Marilena Romero; Gianni Tognoni
Journal:  Eur J Clin Pharmacol       Date:  2011-07-20       Impact factor: 2.953

5.  Expectations of patients and parents of children with asthma regarding access to complementary therapy information and services via the NHS: a qualitative study.

Authors:  Alison Shaw; Elizabeth A Thompson; Deborah J Sharp
Journal:  Health Expect       Date:  2006-12       Impact factor: 3.377

6.  How the internet affects patients' experience of cancer: a qualitative study.

Authors:  Sue Ziebland; Alison Chapple; Carol Dumelow; Julie Evans; Suman Prinjha; Linda Rozmovits
Journal:  BMJ       Date:  2004-03-06

7.  Disclosure of complementary and alternative medicine to conventional medical providers: variation by race/ethnicity and type of CAM.

Authors:  Maria T Chao; Christine Wade; Fredi Kronenberg
Journal:  J Natl Med Assoc       Date:  2008-11       Impact factor: 1.798

8.  Comparing Two Questionnaires for Eliciting CAM Use in a Multi-Ethnic US Population of Older Adults.

Authors:  Sara A Quandt; Edward H Ip; Santiago Saldana; Thomas A Arcury
Journal:  Eur J Integr Med       Date:  2012-01-20       Impact factor: 1.314

9.  "Doing prescribing": how might clinicians work differently for better, safer care.

Authors:  G Elwyn; A Edwards; N Britten
Journal:  Qual Saf Health Care       Date:  2003-12

10.  Australian women's use of complementary and alternative medicines to enhance fertility: exploring the experiences of women and practitioners.

Authors:  Jo-Anne Rayner; Helen L McLachlan; Della A Forster; Rhian Cramer
Journal:  BMC Complement Altern Med       Date:  2009-12-15       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.